Brief reportSeasonality of Coronavirus 229E, HKU1, NL63, and OC43 From 2014 to 2020
Abbreviations and Acronyms
Cited by (0)
Grant Support: Dr Patel reports grants from CD Diagnostics, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, ContraFect, TenNor Therapeutics Limited, and Shionogi.
Potential Competing Interests: Dr Patel is a consultant to Curetis, Specific Technologies, Next Gen Diagnostics, PathoQuest, Selux Diagnostics, 1928 Diagnostics, PhAST and Qvella; monies are paid to Mayo Clinic. In addition, Dr Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. Dr Patel receives travel reimbursement from ASM and IDSA, an editor’s stipend from IDSA, and honoraria from the NBME, Up-to-Date and the Infectious Diseases Board Review Course. Dr Binnicker is an Advisory Board member for DiaSorin Molecular. The other authors report no competing interests.